BioCentury
ARTICLE | Finance

Legend’s $424M NASDAQ offering pads 2020’s lead over prior years

This year’s IPO tally stands at $6.2B, ahead of the past two years thanks to larger deals

June 6, 2020 2:32 AM UTC

Closely-watched CAR T company Legend raised more than $400 million Friday in the year's largest biotech IPO thus far. The deal helped push the total raised via life sciences IPOs to $6.2 billion, outpacing the past two years thanks to larger deals, even as the pandemic has roiled markets around the globe.

Life sciences IPOs raised $3.6 billion in the same time period in both 2018 and 2019 across 28 and 34 offerings, respectively. Through June 5, 25 companies have gone public this year...